These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 31036561)

  • 1. Fyn kinase regulates misfolded α-synuclein uptake and NLRP3 inflammasome activation in microglia.
    Panicker N; Sarkar S; Harischandra DS; Neal M; Kam TI; Jin H; Saminathan H; Langley M; Charli A; Samidurai M; Rokad D; Ghaisas S; Pletnikova O; Dawson VL; Dawson TM; Anantharam V; Kanthasamy AG; Kanthasamy A
    J Exp Med; 2019 Jun; 216(6):1411-1430. PubMed ID: 31036561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.
    Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T
    Front Immunol; 2021; 12():719807. PubMed ID: 34691027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fyn Kinase Regulates Microglial Neuroinflammatory Responses in Cell Culture and Animal Models of Parkinson's Disease.
    Panicker N; Saminathan H; Jin H; Neal M; Harischandra DS; Gordon R; Kanthasamy K; Lawana V; Sarkar S; Luo J; Anantharam V; Kanthasamy AG; Kanthasamy A
    J Neurosci; 2015 Jul; 35(27):10058-77. PubMed ID: 26157004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice.
    Gordon R; Albornoz EA; Christie DC; Langley MR; Kumar V; Mantovani S; Robertson AAB; Butler MS; Rowe DB; O'Neill LA; Kanthasamy AG; Schroder K; Cooper MA; Woodruff TM
    Sci Transl Med; 2018 Oct; 10(465):. PubMed ID: 30381407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia.
    Trudler D; Nazor KL; Eisele YS; Grabauskas T; Dolatabadi N; Parker J; Sultan A; Zhong Z; Goodwin MS; Levites Y; Golde TE; Kelly JW; Sierks MR; Schork NJ; Karin M; Ambasudhan R; Lipton SA
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33833060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
    Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T
    J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fyn amplifies NLRP3 inflammasome signaling in Parkinson's disease.
    Panicker N; Kanthasamy A; Kanthasamy AG
    Aging (Albany NY); 2019 Aug; 11(16):5871-5873. PubMed ID: 31454793
    [No Abstract]   [Full Text] [Related]  

  • 8. Involvement of c-Abl Kinase in Microglial Activation of NLRP3 Inflammasome and Impairment in Autolysosomal System.
    Lawana V; Singh N; Sarkar S; Charli A; Jin H; Anantharam V; Kanthasamy AG; Kanthasamy A
    J Neuroimmune Pharmacol; 2017 Dec; 12(4):624-660. PubMed ID: 28466394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
    Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
    J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson's disease.
    Pike AF; Longhena F; Faustini G; van Eik JM; Gombert I; Herrebout MAC; Fayed MMHE; Sandre M; Varanita T; Teunissen CE; Hoozemans JJM; Bellucci A; Veerhuis R; Bubacco L
    J Neuroinflammation; 2022 Feb; 19(1):50. PubMed ID: 35172843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echinacoside exerts neuroprotection via suppressing microglial α-synuclein/TLR2/NF-κB/NLRP3 axis in parkinsonian models.
    Yang XP; Huang JH; Ye FL; Yv QY; Chen S; Li WW; Zhu M
    Phytomedicine; 2024 Jan; 123():155230. PubMed ID: 38000105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthocyanins from
    Molagoda IMN; Lee KT; Choi YH; Jayasingha JACC; Kim GY
    Oxid Med Cell Longev; 2021; 2021():1246491. PubMed ID: 33613822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Synuclein evokes NLRP3 inflammasome-mediated IL-1β secretion from primary human microglia.
    Pike AF; Varanita T; Herrebout MAC; Plug BC; Kole J; Musters RJP; Teunissen CE; Hoozemans JJM; Bubacco L; Veerhuis R
    Glia; 2021 Jun; 69(6):1413-1428. PubMed ID: 33506583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease.
    Zhou Y; Lu M; Du RH; Qiao C; Jiang CY; Zhang KZ; Ding JH; Hu G
    Mol Neurodegener; 2016 Apr; 11():28. PubMed ID: 27084336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
    Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
    Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin Mac1 mediates paraquat and maneb-induced learning and memory impairments in mice through NADPH oxidase-NLRP3 inflammasome axis-dependent microglial activation.
    Hou L; Liu J; Sun F; Huang R; Chang R; Ruan Z; Wang Y; Zhao J; Wang Q
    J Neuroinflammation; 2023 Feb; 20(1):42. PubMed ID: 36804009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.
    Codolo G; Plotegher N; Pozzobon T; Brucale M; Tessari I; Bubacco L; de Bernard M
    PLoS One; 2013; 8(1):e55375. PubMed ID: 23383169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins.
    Deora V; Lee JD; Albornoz EA; McAlary L; Jagaraj CJ; Robertson AAB; Atkin JD; Cooper MA; Schroder K; Yerbury JJ; Gordon R; Woodruff TM
    Glia; 2020 Feb; 68(2):407-421. PubMed ID: 31596526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
    Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
    Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective.
    Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; Jabir MS; Saad HM; Batiha GE
    J Cell Mol Med; 2023 Jul; 27(13):1775-1789. PubMed ID: 37210624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.